UK Study to Test Schedule of Mixed Covid-19 Vaccine Doses in Children


A UK study is going to be looking into the immune responses of the children to the mixed schedules of the different novel corona virus vaccines as the officials have been trying to determine the best approach to the second novel corona virus vaccines does in the adolescents that has given a small risk of heart inflammation.

The children between the age of 12 years to 15 years in the United Kingdom are going to be vaccinated from the upcoming week, and the children between the age of 16 to 17 years have been receiving the vaccine shots since August 2021.

Although, as the children are going to be offered a first dose of the Pfizer and BioNTech novel corona virus vaccine, the officials said that, the advice for the second dose of the vaccine will be given later, and the Joint Committee on Vaccination and Immunisation (JCVI) of the United Kingdom has initially declined to recommend the corona virus vaccine shots for all the children between 12 years to 15 years of age, that have been citing the uncertainty over the impact of myocarditis, which is a rare side effect of vaccines based on mRNA for a longer period.

READ  Study: Pfizer’s Paxlovid Can Lower Post-COVID Symptoms

The study, which is called as Com-COV3, is going to be testing the different schedules of the corona virus vaccines in the 12 years to 16 years old children, along with looking at the response of the immune system and the milder side effects of the vaccine.